Stock price when the opinion was issued
Hospital supplies. Tends to be a little more volatile because it is a turnaround story. Also, doesn’t have a dividend. If you don’t like volatility, consider Covidian (COV-N) which is a better alternative. He believes ultimately this will be taken out because the CEO has a track record of going in, fixing up and selling companies.
(A Top Pick July 31/13. Up 12%.) This company is in prosthetics, specializing in extremities such as toes, fingers, wrists, etc. If you have health insurance, you are more likely to get work that needs done than if you don’t have it. Has been held back compared to some competitors because there have been takeovers of competitors. Would still be a buyer. $36 in 12 months would be a reasonable estimate.
Big growth is coming from extremities – fingers and toes. Baby boomers are getting new toes, fingers and hips. It is also a turn-around story. In ’09 there was some regulatory misconduct.